Phase II trial of concurrent chemoradiotherapy with S1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 687-691

Science Publishers

Access to resources Recommend Favorite

Serum Lactate Dehydrogenase Level is a Prognostic Factor in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy

By Turen Selahattin   Ozyar Enis   Altundag Kadri   Gullu Ibrahim   Atahan Ibtisam L.  

Cancer Investigation, Vol. 25, Iss. 5, 2007-07 ,pp. : 315-321

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

By      

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1123-1130

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

By Dimopoulos M.A.   Papadimitriou C.A.   Georgoulias V.   Moulopoulos L.A.   Aravantinos G.   Gika D.   Karpathios S.   Stamatelopoulos S.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 52-57

Elsevier

Access to resources Recommend Favorite

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma

By Yeo W.   Leung T.W.T.   Chan A.T.C.   Chiu S.K.W.   Yu P.   Mok T.S.K.   Johnson P.J.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2027-2031

Elsevier

Access to resources Recommend Favorite